Literature DB >> 34737919

Multidetector computed tomography assessment of vascular involvement in perihilar cholangiocarcinoma.

Lotte C Franken1, Robert J S Coelen1, Joris I Erdmann1, Joanne Verheij2, Marnix P Kop3, Thomas M van Gulik1, Saffire S Phoa3.   

Abstract

BACKGROUND: In approximately 40% of patients with perihilar cholangiocarcinoma (PHC), the tumor is deemed unresectable at laparotomy, often due to vascular involvement. On imaging, occlusion, narrowing, wall irregularity and >180° tumor-vessel contact have been suggested to predict vascular involvement in patients with PHC. The objective of this study was to correlate computed tomography (CT) findings in PHC with surgical and histopathological results, in order to evaluate the accuracy of currently used CT criteria for vascular involvement.
METHODS: Patients with PHC undergoing exploration in a single tertiary center (2015-2018) were included. Tumor-vessel relation of portal vein and hepatic artery on CT were scored by two independent radiologists, blinded for surgical and pathological outcomes. Intraoperative findings were scored by the surgeon in theatre or derived from operation/pathology reports.
RESULTS: A total of 42 CT scans were evaluated, resulting in assessment of 115 vessels. Portal vein occlusion, narrowing and presence of an irregular wall on CT corresponded with a positive predictive value (PPV) for involvement of 100%, 83% and 75%, respectively. For the hepatic artery, PPV of occlusion and stenosis was 100%, whilst other criteria had PPV <70%. Combining potential criteria (>180° contact, narrowing, irregularity or occlusion) resulted in PPV, sensitivity and specificity of 85%, 67% and 94%, respectively, for the portal vein and 53%, 40% and 75%, respectively, for the hepatic artery.
CONCLUSIONS: Prediction of vascular involvement on CT is more difficult for the hepatic artery than for the portal vein. Suggestion of hepatic artery invasion on imaging, other than occlusion or stenosis, should not preclude surgical exploration. 2021 Quantitative Imaging in Medicine and Surgery. All rights reserved.

Entities:  

Keywords:  Perihilar cholangiocarcinoma (PHC); computed tomography (CT); hepatic artery; portal vein; resectability; vascular involvement

Year:  2021        PMID: 34737919      PMCID: PMC8511726          DOI: 10.21037/qims-20-1303

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN: 2223-4306


  14 in total

Review 1.  Assessment of pathology reports on hilar cholangiocarcinoma: the results of a nationwide, multicenter survey performed by the AFC-HC-2009 study group.

Authors:  Denis Chatelain; Olivier Farges; David Fuks; Nathalie Trouillet; François René Pruvot; Jean-Marc Regimbeau
Journal:  J Hepatol       Date:  2012-01-13       Impact factor: 25.083

2.  Preoperative Risk Score to Predict Occult Metastatic or Locally Advanced Disease in Patients with Resectable Perihilar Cholangiocarcinoma on Imaging.

Authors:  Jimme K Wiggers; Bas Groot Koerkamp; David van Klaveren; Robert J Coelen; C Yung Nio; Peter J Allen; Marc G Besselink; Olivier R Busch; Michael I D'Angelica; Ronald P DeMatteo; T Peter Kingham; Thomas M van Gulik; William R Jarnagin
Journal:  J Am Coll Surg       Date:  2018-04-06       Impact factor: 6.113

3.  New staging system and a registry for perihilar cholangiocarcinoma.

Authors:  Michelle L Deoliveira; Richard D Schulick; Yuji Nimura; Charles Rosen; Gregory Gores; Peter Neuhaus; Pierre-Alain Clavien
Journal:  Hepatology       Date:  2011-04       Impact factor: 17.425

4.  Modification and establishment of CT criteria in preoperative assessment of portal venous invasion by hilar cholangiocarcinoma.

Authors:  Qun Zhou; Yue Guan; Liang Mao; Yong Zhu; Jun Chen; Jiong Shi; Min Tang; Yudong Qiu; Bin Zhu; Jian He
Journal:  HPB (Oxford)       Date:  2018-07-18       Impact factor: 3.647

Review 5.  Radiological staging in patients with hilar cholangiocarcinoma: a systematic review and meta-analysis.

Authors:  A T Ruys; B E van Beem; M R W Engelbrecht; S Bipat; J Stoker; T M Van Gulik
Journal:  Br J Radiol       Date:  2012-09       Impact factor: 3.039

6.  MDCT assessment of resectability in hilar cholangiocarcinoma.

Authors:  Qihong Ni; Haolu Wang; Yunhe Zhang; Lijun Qian; Jiachang Chi; Xiaowen Liang; Tao Chen; Jian Wang
Journal:  Abdom Radiol (NY)       Date:  2017-03

7.  The Blumgart preoperative staging system for hilar cholangiocarcinoma: analysis of resectability and outcomes in 380 patients.

Authors:  Kenichi Matsuo; Flavio G Rocha; Kaori Ito; Michael I D'Angelica; Peter J Allen; Yuman Fong; Ronald P Dematteo; Mithat Gonen; Itaru Endo; William R Jarnagin
Journal:  J Am Coll Surg       Date:  2012-06-28       Impact factor: 6.113

8.  Preoperative assessment of resectability of hepatic hilar cholangiocarcinoma: combined CT and cholangiography with revised criteria.

Authors:  Ho Yun Lee; Se Hyung Kim; Jeong Min Lee; Sun-Whe Kim; Jin-Young Jang; Joon Koo Han; Byung Ihn Choi
Journal:  Radiology       Date:  2006-02-07       Impact factor: 11.105

Review 9.  Borderline resectable pancreatic cancer: conceptual evolution and current approach to image-based classification.

Authors:  J W Gilbert; B Wolpin; T Clancy; J Wang; H Mamon; A B Shinagare; J Jagannathan; M Rosenthal
Journal:  Ann Oncol       Date:  2017-09-01       Impact factor: 32.976

Review 10.  Modern work-up and extended resection in perihilar cholangiocarcinoma: the AMC experience.

Authors:  F Rassam; E Roos; K P van Lienden; J E van Hooft; H J Klümpen; G van Tienhoven; R J Bennink; M R Engelbrecht; A Schoorlemmer; U H W Beuers; J Verheij; M G Besselink; O R Busch; T M van Gulik
Journal:  Langenbecks Arch Surg       Date:  2018-01-19       Impact factor: 3.445

View more
  2 in total

1.  Multidetector computed tomography assessment of venous invasion in hepatic alveolar echinococcosis.

Authors:  Tieliang Zhang; Yuan Zhang; Jian Wang; Juan Hou; Wenya Liu
Journal:  Abdom Radiol (NY)       Date:  2022-10-07

2.  Conventional, functional and radiomics assessment for intrahepatic cholangiocarcinoma.

Authors:  Vincenza Granata; Roberta Fusco; Andrea Belli; Valentina Borzillo; Pierpaolo Palumbo; Federico Bruno; Roberta Grassi; Alessandro Ottaiano; Guglielmo Nasti; Vincenzo Pilone; Antonella Petrillo; Francesco Izzo
Journal:  Infect Agent Cancer       Date:  2022-03-28       Impact factor: 2.965

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.